155 related articles for article (PubMed ID: 11035093)
21. Identification of an ICP27-responsive element in the coding region of a herpes simplex virus type 1 late gene.
Sedlackova L; Perkins KD; Meyer J; Strain AK; Goldman O; Rice SA
J Virol; 2010 Mar; 84(6):2707-18. PubMed ID: 20042503
[TBL] [Abstract][Full Text] [Related]
22. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
23. Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection.
Judson KA; Lubinski JM; Jiang M; Chang Y; Eisenberg RJ; Cohen GH; Friedman HM
J Virol; 2003 Dec; 77(23):12639-45. PubMed ID: 14610186
[TBL] [Abstract][Full Text] [Related]
24. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.
Bender FC; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ
J Virol; 2005 Sep; 79(18):11588-97. PubMed ID: 16140736
[TBL] [Abstract][Full Text] [Related]
26. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
[TBL] [Abstract][Full Text] [Related]
27. The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes.
Musarrat F; Jambunathan N; Rider PJF; Chouljenko VN; Kousoulas KG
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321326
[TBL] [Abstract][Full Text] [Related]
28. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.
Tal-Singer R; Peng C; Ponce De Leon M; Abrams WR; Banfield BW; Tufaro F; Cohen GH; Eisenberg RJ
J Virol; 1995 Jul; 69(7):4471-83. PubMed ID: 7769707
[TBL] [Abstract][Full Text] [Related]
29. Direct binding of herpes simplex virus type 1 virions to complement C3.
Chen YT; Wang YH; Cheng YY; Hung SL
Viral Immunol; 2003; 16(3):347-55. PubMed ID: 14583149
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
McNearney TA; Odell C; Holers VM; Spear PG; Atkinson JP
J Exp Med; 1987 Nov; 166(5):1525-35. PubMed ID: 2824652
[TBL] [Abstract][Full Text] [Related]
31. Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene.
Cunha CW; Taylor KE; Pritchard SM; Delboy MG; Komala Sari T; Aguilar HC; Mossman KL; Nicola AV
PLoS One; 2015; 10(7):e0131129. PubMed ID: 26186447
[TBL] [Abstract][Full Text] [Related]
32. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
33. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of a viral target gene by herpes simplex virus ICP27 is posttranscriptional and does not require the endogenous promoter or polyadenylation site.
Perkins KD; Gregonis J; Borge S; Rice SA
J Virol; 2003 Sep; 77(18):9872-84. PubMed ID: 12941897
[TBL] [Abstract][Full Text] [Related]
35. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.
Johnson JB; Capraro GA; Parks GD
Virology; 2008 Jun; 376(1):112-23. PubMed ID: 18440578
[TBL] [Abstract][Full Text] [Related]
36. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
37. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.
Adamiak B; Trybala E; Mardberg K; Johansson M; Liljeqvist JA; Olofsson S; Grabowska A; Bienkowska-Szewczyk K; Szewczyk B; Bergstrom T
Virology; 2010 May; 400(2):197-206. PubMed ID: 20176392
[TBL] [Abstract][Full Text] [Related]
38. Real time observation of the binding of herpes simplex virus type 1 (HSV-1) to immobilized heparan sulfate and the neutralization of HSV-1 by sulfonated human immunoglobulin.
Inoue K; Arai T; Aoyagi M
J Biochem; 1996 Aug; 120(2):233-5. PubMed ID: 8889804
[TBL] [Abstract][Full Text] [Related]
39. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
40. gp13 (EHV-gC): a complement receptor induced by equine herpesviruses.
Huemer HP; Nowotny N; Crabb BS; Meyer H; Hübert PH
Virus Res; 1995 Jul; 37(2):113-26. PubMed ID: 7483825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
